Sentence examples for proprietary bead from inspiring English sources

Genotypes were obtained using the proprietary Bead Studio software.

Multianalyte profiling (xMAP) technology from Luminex (http://www.luminexcorp.com/) and several other companies employ proprietary bead sets which are distinguishable under flow cytometry.

The unique feature of MPSS was the proprietary, bead-based sequencing technology, which was more efficient than standard Sanger sequencing and yielded far larger tag counts.

Following PCR amplification, these mate-pair libraries are then used as templates in emulsion PCR reactions using SOLiD™ proprietary sequencing beads to generate clonal single molecule templated beads.

RNA was isolated from 268 FFPE tumour tissue samples employing an experimental method based on proprietary magnetic beads from Siemens Healthcare Diagnostics (Cologne, Germany).

Intact RNA with high quality, as determined by analysis of the housekeeping gene RPL37A, was isolated from 181 FFPE samples from the HeCOG cohort by using an experimental method based on proprietary magnetic beads from Siemens Healthcare Diagnostics Products GmbH (Cologne, Germany), as previously described (Pentheroudakis et al, 2009).

Typically GITC is removed by extraction with phenol-chloroform and purification of the nucleic acids through alcohol precipitation cycles [ 9], or by absorption of the freed RNA to a matrix such as glass fiber filters, silica-gel membranes, magnetic beads or proprietary compositions, usually followed by elution in a relatively large volume.

Statistical significance was calculated with the Illumina DiffScore, a proprietary algorithm that uses the bead standard deviation to build an error model.

Data of the Illumina arrays was processed with Bead Studio (Illumina's proprietary software).

USL255, Qudexy XR (topiramate) extended-release capsules (Upsher-Smith, Maple Grove, MN, U.S.A ., is a proprietary once-daily XR topiramate formulation that was developed using a coated-bead technology to deliver consistent drug release over a 24 h dosing interval.

Luminex uses proprietary techniques to internally color code microspheres with two fluorescent dyes and to create distinctly colored bead sets of 500 5.6 μm polystyrene microspheres or 80 6.45 μm magnetic microspheres, each of which is coated with a specific capture antibody.